Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Aug 7, 2014 · 10-Q · 38 days after period end · 0001193125-14-300691
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Net Income | -$7.02M | -$8.42M | -$4.22M | -$6.53M |
| EPS Diluted | -$0.47 | -$0.57 | -$0.29 | -$0.67 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Jun 30, 2014 · filed Aug 7, 2014 · 38 d after period end
